Graphium biosciences inc
Web--MALACHITE INNOVATIONS, INC. announces that its wholly-owned drug development subsidiary, Graphium Biosciences, Inc., has been granted two patents by the U.S. … Web4.4K 52-Wk Range 0.1201 - 0.2986 (04/28/22 - 10/11/22) 33.22% Historical Volatility 149.3% Market Cap 12.5M Shares Outstanding 78.1M EPS (TTM, GAAP) -0.03 P/E Ratio (TTM, GAAP) -- Annual Dividend/Yield No dividend Ex-dividend Date No dividend Dividend Pay Date No dividend Beta 2.6 % Held by Institutions 0.10 Short Interest --
Graphium biosciences inc
Did you know?
WebMar 30, 2024 · About MLCT. Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside … WebThe meaning of GRAPHIUM is a form genus of imperfect fungi (family Stilbellaceae) with dark-colored coremia many of which (as the parasite of Dutch elm disease) have been …
WebApr 5, 2024 · Graphium Biosciences, Inc. ("Graphium") is a cannabinoid-based drug development company tracing its history of technological innovation and drug … WebDec 28, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel cannabinoid-glycoside compounds created using our proprietary enzymatic bioprocessing technologies to develop safe and effective novel treatments for chronic and debilitating …
WebApr 6, 2024 · Graphium Biosciences, Inc. is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to … WebApr 5, 2024 · Graphium Biosciences, Inc. (“Graphium”) is a cannabinoid-based drug development company tracing its history of technological innovation and drug …
WebLatest Graphium Biosciences, Inc. Patents: CANNABINOID GLYCOSIDES AND USES THEREOF CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF …
WebOct 26, 2024 · Type: Grant Filed: September 22, 2016 Date of Patent: December 28, 2024 Assignee: Graphium Biosciences, Inc. Inventors: Brandon J. Zipp, Janee M. Hardman, … sims murphy memphisWebSep 22, 2016 - Graphium Biosciences, Inc. The present invention relates to cannabinoid glycoside prodrugs suitable for site- and tissue-specific delivery of cannabinoid molecules. The present invention also relates to methods of forming the cannabinoid glycoside prodrugs through glycosyltransferase mediated glycosylation of cannabinoid molecules. rcsc in bhutanWebSince we were founded in 1989, we've focused on providing innovative solutions for education and business. Get in touch. 45190 Prologis Plaza, Suite 165. Dulles , VA … rcs clinicWebMar 31, 2024 · Its Graphium Biosciences, Inc. is focused on advancing its portfolio of over 100 cannabinoid-glycoside compounds created using its enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions. Daedalus Ecosciences, Inc. (Daedalus). is focused on the health and wellness through … rcs coatingsWebDec 29, 2024 · Graphium Biosciences has been granted a patent by the USPTO for its “Cannabinoid Glycoside Prodrugs and Methods of Synthesis” that involves its invention … rcs computersWebDec 31, 2024 · Graphium Biosciences, Inc. (“Graphium”) is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to October 2011 through two predecessor entities, Stevia First Corp. and Vitality Biopharma, Inc. In October 2024, Malachite formed Graphium as a wholly-owned … rcs clusterWebApr 5, 2024 · Graphium Biosciences, Inc. ("Graphium") is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to October 2011 through two ... rcsc.max online